Clarivate to Sell Life Sciences & Healthcare Business to Altaris for $600 Million

Corporate Action
โดย Insider Monkey·Read original
Summary · why it matters

Clarivate has signed a definitive agreement to sell its Life Sciences & Healthcare segment to Altaris for approximately $600 million. The deal includes $500 million in cash, a $75 million seller note, and $25 million in deferred cash tied to transition services. The company plans to use the proceeds to reduce debt and will become a subscription-first provider of technology-enabled services, intelligence solutions, and workflow software upon completion.

Impact on stocks 1

Artificial Intelligence▲ · 1 stocks
CLARIVATE PLC
CLVT
▲ PositiveCapitalrelevance

Sells segment for $600M, uses proceeds to reduce debt, becoming subscription-first provider.

Off-coverage companies 1

Altaris Capital PartnersPrivate± Mixed
relevance

© 2026 MarketDXNews